1)花尻(木倉)瑠理:日本における違法ドラッグ対策—指定薬物制度について.ファルマシア44(12):1177-1182, 2008
2)Kikura-Hanajiri R, et al:Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Med 13(3):109-115, 2011
3)花尻(木倉)瑠理,他:違法ドラッグを取り巻く国内外における現状と規制について.薬学雑誌133(1):31-40, 2013
4)Kikura-Hanajiri R, et al:Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan. Drug Test Anal 6(7-8):832-839, 2014
5)花尻(木倉)瑠理:危険ドラッグの規制と流通実態について.薬剤学75(2):121-127, 2015
6)Compton DR, et al:Cannabinoid structure-activity relationships:Correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265(1):218-226, 1993
7)Aung MM, et al:Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depen 60(2):133-140, 2000
8)Buchler IP, et al:Indazole derivatives as CB1 receptor modulators and their preparation and use in treatment of diseases. Patent:WO/2009/106980 September, 2009